Compartilhar
Informação da revista
Vol. 43. Núm. S3.
Páginas S54 (novembro 2021)
Vol. 43. Núm. S3.
Páginas S54 (novembro 2021)
PP 58
Open Access
ETIOLOGY, TREATMENT AND FOLLOW-UP OF THROMBOSIS IN CHILDREN, ONE CENTER PROSPECTIVE TRIAL
Visitas
1797
Yunus Murat Akcabelen1, Volkan Köse1, Dilek Gürlek Gökçebay1, Turan Bayhan1, Neşe Yaralı2, Namık Yaşar Özbek1
1 University of Health Sciences, Ankara City Hospital, Pediatric Hematology and Oncology
2 Ankara Yıldırım Beyazıt University Ankara City Hospital, Pediatric Hematology and Oncology
Este item recebeu

Under a Creative Commons license
Informação do artigo
Suplemento especial
Este artigo faz parte de:
Vol. 43. Núm S3
Mais dados
Objective

The aim of the study; To determine the frequency, etiological factors, treatment, long-term follow-up and recurrence rates of thrombosis in children.

Methodology

Children with thrombosis in Ankara City Hospital between December 2018 and August 2021 were included. Patients were called or examined at 6–12-month intervals.

Results

A total of 328 patients with a mean age of 6.9 were included.Catheter-related thrombosis was present in 52.7%.There were 14% arterial thrombosis and 59% venous thrombosis.Intracardiac thrombosis 16.2%, pulmonar thrombosis 2.4%, serebral thromboembolism %20 were detected.In the treatment, subcutaneous ondansetron (78.6%) was used mostly, but intravenous ondansetron was given in 6 patients and TPA was given 20 patients.In a mean follow-up of 15.8 months, 5 (1.5%) patients died due to thrombosis.

Conclusion

Determining the etiological factors of patients with recurrence thrombosis is important for the duration of treatment in the follow-up.

O texto completo está disponível em PDF
Baixar PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Opções de artigo
Ferramentas